Targeting aberrant colon cancer-specific DNA methylation with lipoteichoic acid-deficient Lactobacillus acidophilus

Gut Microbes

Volumn 4, Issue 1, 2013, Pages

  Lightfoot, Yaíma L ^a   Yang, Tao ^a   Sahay, Bikash ^a   Mohamadzadeh, Mansour ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Aberrant epigenetic alterations; Colorectal cancer; DNA methylation; Inflammation; Lipoteichoic acid

Indexed keywords

APC PROTEIN; CYTOKINE; DNA METHYLTRANSFERASE 1; GAMMA INTERFERON; INTERLEUKIN 6; LIPOTEICHOIC ACID; METHYL CPG BINDING PROTEIN; PHOSPHATASE; TENSIN; UNTRANSLATED RNA; LIPOPOLYSACCHARIDE; TEICHOIC ACID;

ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL DAMAGE; COLON CANCER; COLON POLYP; COLORECTAL CANCER; DNA METHYLATION; DNA MODIFICATION; ENTERITIS; EPIGENETICS; GENE EXPRESSION; GENE MUTATION; HISTONE MODIFICATION; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; INTESTINE; LACTOBACILLUS ACIDOPHILUS; NONHUMAN; PATTERN RECOGNITION RECEPTOR; REAL TIME POLYMERASE CHAIN REACTION; ABERRANT EPIGENETIC ALTERATIONS; ANIMAL; BIOLOGICAL THERAPY; COLON TUMOR; GENE EXPRESSION PROFILING; GENETIC EPIGENESIS; INFLAMMATION; METABOLISM; METHODOLOGY; PATHOLOGY; REVIEW; TUMOR SUPPRESSOR GENE;

BACTERIA (MICROORGANISMS); LACTOBACILLUS ACIDOPHILUS;

ABERRANT EPIGENETIC ALTERATIONS; COLORECTAL CANCER; DNA METHYLATION; INFLAMMATION; LIPOTEICHOIC ACID;

ANIMALS; BIOLOGICAL THERAPY; COLONIC NEOPLASMS; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; GENES, TUMOR SUPPRESSOR; HUMANS; LACTOBACILLUS ACIDOPHILUS; LIPOPOLYSACCHARIDES; TEICHOIC ACIDS;

EID: 84871770219     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.22822     Document Type: Article

References (29)

1. Rossi O, van Baarlen P, Wells JM. Host-Recognition of Pathogens and Commensals in the Mammalian Intestine. Curr Top Microbiol Immunol 2011; PMID:22179258; http://dx.doi. org/10.1007/82_2011_191.
2. Kelsall BL, Leon F. Involvement of intestinal dendritic cells in oral tolerance, immunity to pathogens, and inflammatory bowel disease. Immunol Rev 2005; 206:132-48; PMID:16048546; http://dx.doi. org/10.1111/j.0105-2896.2005.00292.x.
3. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010; 140:883-99; PMID:20303878; http://dx.doi.org/10.1016/j. cell.2010.01.025.
4. Rubin DC, Shaker A, Levin MS. Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer. Front Immunol 2012; 3:107; PMID:22586430; http://dx.doi.org/10.3389/fimmu.2012.00107.
5. Watson AJ, Collins PD. Colon cancer: a civilization disorder. Dig Dis 2011; 29:222-8; PMID:21734388; http://dx.doi.org/10.1159/000323926.
6. Tjalsma H, Boleij A, Marchesi JR, Dutilh BE. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol 2012; 10:575-82; PMID:22728587; http://dx.doi. org/10.1038/nrmicro2819.
7. Terzić J, Grivennikov S, Karin E, Karin M. Inflammation and colon cancer. Gastroenterology 2010; 138:2101-14, e5; PMID:20420949; http://dx.doi.org/10.1053/j.gastro.2010.01.058.
8. Khazaie K, Zadeh M, Khan MW, Bere P, Gounari F, Dennis K, et al. Abating colon cancer polyposis by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc Natl Acad Sci U S A 2012; 109:10462-7; PMID:22689992; http://dx.doi.org/10.1073/pnas.1207230109.
9. Fearon ER. Molecular genetics of colorectal cancer. Annu Rev Pathol 2011; 6:479-507; PMID:21090969; http://dx.doi.org/10.1146/annurev-pathol-011110-130235.
10. Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis 2010; 31:27-36; PMID:19752007; http://dx.doi.org/10.1093/carcin/bgp220
11. Lao VV, Grady WM. Epigenetics and colorectal cancer. Nat Rev Gastroenterol Hepatol 2011; 8:686-700; PMID:22009203; http://dx.doi.org/10.1038/nrgastro.2011.173.
12. Schuebel KE, Chen W, Cope L, Glöckner SC, Suzuki H, Yi JM, et al. Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet 2007; 3:1709-23; PMID:17892325; http://dx.doi.org/10.1371/journal.pgen.0030157.
13. Kiefer JC. Epigenetics in development. Dev Dyn 2007; 236:1144-56; PMID:17304537; http://dx.doi. org/10.1002/dvdy.21094.
14. Hartnett L, Egan LJ. Inflammation, DNA methylation and colitis-associated cancer. Carcinogenesis 2012; 33:723-31; PMID:22235026; http://dx.doi. org/10.1093/carcin/bgs006.
15. Saito S, Kato J, Hiraoka S, Horii J, Suzuki H, Higashi R, et al. DNA methylation of colon mucosa in ulcerative colitis patients: correlation with inflammatory status. Inflamm Bowel Dis 2011; 17:1955-65; PMID:21830274; http://dx.doi.org/10.1002/ibd.21573.
16. Grivennikov S, Karin E, Terzic J, Mucida D, Yu GY, Vallabhapurapu S, et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 2009; 15:103-13; PMID:19185845; http://dx.doi. org/10.1016/j.ccr.2009.01.001.
17. Grivennikov SI, Karin M. Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage. Ann Rheum Dis 2011; 70(Suppl 1):i104-8; PMID:21339211; http://dx.doi.org/10.1136/ard.2010.140145.
18. Foran E, Garrity-Park MM, Mureau C, Newell J, Smyrk TC, Limburg PJ, et al. Upregulation of DNA methyltransferase-mediated gene silencing, anchorage-independent growth, and migration of colon cancer cells by interleukin-6. Mol Cancer Res 2010; 8:471-81; PMID:20354000; http://dx.doi. org/10.1158/1541-7786.MCR-09-0496.
19. Kominsky DJ, Keely S, MacManus CF, Glover LE, Scully M, Collins CB, et al. An endogenously anti-inflammatory role for methylation in mucosal inflammation identified through metabolite profiling. J Immunol 2011; 186:6505-14; PMID:21515785; http://dx.doi.org/10.4049/jimmunol.1002805.
20. Mohamadzadeh M, Pfeiler EA, Brown JB, Zadeh M, Gramarossa M, Managlia E, et al. Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc Natl Acad Sci U S A 2011; 108(Suppl 1):4623-30; PMID:21282652; http://dx.doi.org/10.1073/pnas.1005066107.
21. Varley KE, Mitra RD. Bisulfite Patch PCR enables multiplexed sequencing of promoter methylation across cancer samples. Genome Res 2010; 20:1279-87; PMID:20627893; http://dx.doi.org/10.1101/gr.101212.109.
22. Yi JM, Dhir M, Van Neste L, Downing SR, Jeschke J, Glöckner SC, et al. Genomic and epigenomic integration identifies a prognostic signature in colon cancer. Clin Cancer Res 2011; 17:1535-45; PMID:21278247; http://dx.doi.org/10.1158/1078-0432.CCR-10-2509.
23. Wells JM, Rossi O, Meijerink M, van Baarlen P. Epithelial crosstalk at the microbiota-mucosal interface. Proc Natl Acad Sci U S A 2011; 108(Suppl 1):4607-14; PMID:20826446; http://dx.doi. org/10.1073/pnas.1000092107.
24. Zadeh M, Khan MW, Goh YJ, Selle K, Owen JL, Klaenhammer T, et al. Induction of intestinal proinflammatory immune responses by lipoteichoic acid. J Inflamm (Lond) 2012; 9:7; PMID:22423982; http://dx.doi.org/10.1186/1476-9255-9-7.
25. Konstantinov SR, Smidt H, de Vos WM, Bruijns SC, Singh SK, Valence F, et al. S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc Natl Acad Sci U S A 2008; 105:19474-9; PMID:19047644; http://dx.doi.org/10.1073/pnas.0810305105.
26. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science 2012; 336:1268-73; PMID:22674334; http://dx.doi.org/10.1126/science.1223490.
27. Licciardi PV, Wong S-S, Tang ML, Karagiannis TC. Epigenome targeting by probiotic metabolites. Gut Pathogens 2010; 2.
28. Shenderov BA. Gut indigenous microbiota and epigenetics. Microb Ecol Health Dis 2012; 23:17195; http://dx.doi.org/10.3402/mehd.v23i0.17195.
29. Chalhoub N, Baker SJ. PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol 2009; 4:127-50; PMID:18767981; http://dx.doi.org/10.1146/annurev.pathol.4.110807.092311.